CK Life Sciences International (Holdings), Inc. (0775.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap7.88B
Enterprise Value13.9B
P/E Ratio-28.87
PEG Ratio0.23
Price/Sales Ratio0.99
Price/Book Ratio1.44
Enterprise/Revenue2.11
Enterprise/EBITDA-252.41

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-0.03
Operating Margin0.02
AD

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.05

Income Statement

Revenue5.41B
Revenue/Share0.56
Gross Profit785.39M
EBITDA-49.42M
Net Income-188.45M
Diluted EPS-0.02

Balance Sheet

Total Cash603.07M
Total Cash/Share0.06
Total Debt6.62B
Total Debt/Equity1.75
Current Ratio0.87
Book Value Per Share0.4

Price History

52-Week Change-39.78
52-Week High1.08
52-Week Low0.55
Moving Average 50 Days0.63
Moving Average 200 Days0.76

Statistics

Average Volume2.83M
Shares Outstanding9.61B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD